(2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid

C24H33N3O5 — CID 70032234

IUPAC(2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid
SMILESO=C(c1ccc(OCCCN2CCN(C(=O)C[C@H]3CCCN3C(=O)O)CC2)cc1)C1CC1
InChIInChI=1S/C24H33N3O5/c28-22(17-20-3-1-11-27(20)24(30)31)26-14-12-25(13-15-26)10-2-16-32-21-8-6-19(7-9-21)23(29)18-4-5-18/h6-9,18,20H,1-5,10-17H2,(H,30,31)/t20-/m1/s1
InChIKeyFEJJKBIEGYOWGQ-HXUWFJFHSA-N
MW443.54 g/mol
LogP2.72
Rot. Bonds9

About (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid

(2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid (PubChem CID 70032234) has the molecular formula C24H33N3O5 and a molecular weight of 443.54 g/mol. Its IUPAC name is (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid.

Molecular Properties

Compound Name(2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid
PubChem CID70032234
Molecular FormulaC24H33N3O5
Molecular Weight443.54 g/mol
Exact Mass443.24
IUPAC Name(2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid
SMILESO=C(c1ccc(OCCCN2CCN(C(=O)C[C@H]3CCCN3C(=O)O)CC2)cc1)C1CC1
InChIInChI=1S/C24H33N3O5/c28-22(17-20-3-1-11-27(20)24(30)31)26-14-12-25(13-15-26)10-2-16-32-21-8-6-19(7-9-21)23(29)18-4-5-18/h6-9,18,20H,1-5,10-17H2,(H,30,31)/t20-/m1/s1
InChIKeyFEJJKBIEGYOWGQ-HXUWFJFHSA-N
XLogP2.72
TPSA90.39 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500443.54
LogP ≤ 52.72
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid?
The IUPAC name of (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid (CID 70032234) is (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid.
What is the SMILES notation for (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid?
The canonical SMILES for (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid is O=C(c1ccc(OCCCN2CCN(C(=O)C[C@H]3CCCN3C(=O)O)CC2)cc1)C1CC1.
What is the InChIKey of (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid?
The InChIKey is FEJJKBIEGYOWGQ-HXUWFJFHSA-N. The full InChI is InChI=1S/C24H33N3O5/c28-22(17-20-3-1-11-27(20)24(30)31)26-14-12-25(13-15-26)10-2-16-32-21-8-6-19(7-9-21)23(29)18-4-5-18/h6-9,18,20H,1-5,10-17H2,(H,30,31)/t20-/m1/s1.
What are the key properties of (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid?
(2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid has a molecular weight of 443.54 g/mol, XLogP of 2.72, 9 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-oxoethyl]pyrrolidine-1-carboxylic acid is sourced from PubChem (CID 70032234), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).